Experiencia con la biopsia de ganglio centinela dinámico en pacientes con cáncer de pene en el Instituto Nacional de Cancerología
Cargando...
Archivos
Autores
Duarte Niño, César Alberto
Director
Tipo de contenido
Document language:
Español
Fecha
Título de la revista
ISSN de la revista
Título del volumen
Documentos PDF
Resumen
Objetivo: Evaluar la biopsia de ganglio centinela dinámico(BGCD) como método de evaluación ganglionar inguinal para cáncer escamocelular (CEC) de pene en regiones inguinales sin ganglios palpables o con un ganglio palpable y biopsia por aspiración con aguja fina negativa en una única institución. Materiales y Métodos: Se revisó retrospectivamente la historia clínica de los pacientes a quienes se les realizó BGCD desde enero de 2007 a agosto de 2011. Se realizó cálculos estadísticos estándar para establecer el rendimiento de la prueba. Resultados: se realizaron 56 BGCD a 35 pacientes. 12,5% de los ganglios centinela presentaron compromiso metastásico. Dos BGCD resultaron ser falsos negativos en el seguimiento. La sensibilidad fue del 78%, un valor predictivo negativo de 95,9%, tasa de falsos negativos del 22% y 6,7% de complicaciones menores. Conclusiones: La BGCD es un procedimiento adecuado para la estadificación ganglionar de pacientes con CEC de pene, con una baja tasa de complicaciones y puede evitar la linfadenectomía inguinal en la mayoría de los pacientes.
Abstract. Objective: To evaluate the dynamic sentinel lymph‐node biopsy (SLNB) as a staging procedure in groins for squamous cell penile cancer (SCC) with clinically node‐negative and in groins with palpable node with negative fine needle aspiration citology (FNAC) in a single institution. Materials and Methods: We retrospectively reviewed medical records of patients who underwent SLNB from January 2007 to August 2011. Standard statistical calculations were done to establish the performance of the test Results: 56 SLNB were performed in 35 patients. 12.5% of the SNLB were positive for nodal metastasis. Two turned out to be false negatives SLNB at follow‐up. The sensitivity was 78%, negative predictive value 95.9%, false negative rate of 22% and 6.7% minor complications. Conclusions: BGCD is an appropriate procedure for nodal staging of patients with SCC of the penis, with a low rate of complications and inguinal lymphadenectomy can be avoided in most patients.
Abstract. Objective: To evaluate the dynamic sentinel lymph‐node biopsy (SLNB) as a staging procedure in groins for squamous cell penile cancer (SCC) with clinically node‐negative and in groins with palpable node with negative fine needle aspiration citology (FNAC) in a single institution. Materials and Methods: We retrospectively reviewed medical records of patients who underwent SLNB from January 2007 to August 2011. Standard statistical calculations were done to establish the performance of the test Results: 56 SLNB were performed in 35 patients. 12.5% of the SNLB were positive for nodal metastasis. Two turned out to be false negatives SLNB at follow‐up. The sensitivity was 78%, negative predictive value 95.9%, false negative rate of 22% and 6.7% minor complications. Conclusions: BGCD is an appropriate procedure for nodal staging of patients with SCC of the penis, with a low rate of complications and inguinal lymphadenectomy can be avoided in most patients.